Last $80.71 USD
Change Today +0.28 / 0.35%
Volume 181.9K
CVD On Other Exchanges
New York
As of 8:04 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

210 Carnegie Center

Princeton, NJ 08540

United States

Phone: 609-452-4440

Fax: 609-452-9375

from clinical development plans and protocol design to New Drug Applications, and other supporting services. The company offers Xcellerate, a proprietary methodology designed to help optimize clinical trial performance to assist biopharmaceutical companies in improving quality, reducing waste, and decreasing trial timelines. The Xcellerate methodology enables the company to make custom recommendations on site, investigator and geographic selection to improve clinical trial design and execution. The company offers a range of periapproval services, which are studies conducted ‘around the time of New Drug Application approval’, after a drug has undergone clinical efficacy and safety testing and the New Drug Application has been submitted to the Food and Drug Administration (FDA). These services include Treatment Investigational New Drug applications; Phase IIIb clinical studies, which involve studies conducted after New Drug Application submission, and before regulatory approval is obtained; Phase IV clinical studies, which are studies conducted after initial approval of the drug; product withdrawal support services and other types of periapproval studies, such as post-marketing surveillance studies, FDA mandated post-marketing commitments focusing on characterizing a drug's safety in various patient groups; and prescription to over-the-counter switch studies. Market Access Services The company offers a range of reimbursement and healthcare economics consulting services, including outcomes and pharmacoeconomic studies, reimbursement planning, reimbursement advocacy programs, risk evaluation and mitigation strategy (REMS) services, registry services, specialty pharmacy services, and managed market contracting services. It offers InTeleCenter services that employ phone, Internet, and electronic media to manage customer communications. InTeleCenter programs include reimbursement hotlines, patient assistance programs, and patient compliance REMS programs. Clinical Trial Support Services Interactive Voice and Web Response Services: The company sold its interactive voice and Web response services business to Phase Forward. In addition, the company and Phase Forward entered into a five year marketing agreement with respect to certain of Phase Forward's services, which the company offers to its clinical development clients. Cardiac Safety Services: The company offers centralized ECG services to its clients through a long-term marketing arrangement with eResearch Technology Inc. Customers and Marketing In 2013, the company served approximately 1,000 biopharmaceutical companies, ranging from large pharmaceutical companies and biotechnology companies to small and start-up organizations. Its global sales activities are conducted by sales personnel based in its operations in North America, Europe, South America, and the Asia Pacific. Business Strategy The company’s strategy is to provide services that would generate high-quality and timely data in support of new drug approval or use expansion. It does this by developing and delivering high-quality services that apply science, technology and global reach to capture, manage, and integrate a range of drug development data. Government Regulation The company’s clinical services are subject to industry standards for the conduct of clinical research and development studies that are embodied in the regulations for Good Clinical Practice. The company has established quality assurance controls at its laboratory facilities, which monitor ongoing compliance with GLP and the Clinical Laboratory Improvement Amendments of 1988. The company’s animal import and breeding facilities and toxicology facilities are also subject to various U.S. federal and state laws and regulations, including The Animal Welfare Act and the rules and regulations promulgated thereunder by the United States Department of Agriculture, and corresponding rules and regulations in other countries. The company’s laboratories are subject to applicable laws and regulations relating to the storage and disposal of all laboratory specimens, including the regulations of the Environmental Protecti


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVD:US $80.71 USD +0.28

CVD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Catalent Inc $24.94 USD +0.68
Charles River Laboratories International Inc $63.69 USD +1.13
ICON PLC $56.71 USD +0.16
STERIS Corp $59.60 USD -0.75
West Pharmaceutical Services Inc $45.48 USD +0.38
View Industry Companies

Industry Analysis


Industry Average

Valuation CVD Industry Range
Price/Earnings 29.4x
Price/Sales 1.8x
Price/Book 2.8x
Price/Cash Flow 15.8x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVANCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at